世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6061
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、血管内皮増殖因子（VEGF）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別市場規模（腫瘍、眼科）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・血管内皮増殖因子（VEGF）阻害剤の市場動向
・企業の競争状況、市場シェア
・血管内皮増殖因子（VEGF）阻害剤の種類別市場規模と予測2016-2027（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）
・血管内皮増殖因子（VEGF）阻害剤の用途別市場規模と予測2016-2027（腫瘍、眼科）
・血管内皮増殖因子（VEGF）阻害剤の北米市場規模2016-2027（アメリカ、カナダ）
・血管内皮増殖因子（VEGF）阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・血管内皮増殖因子（VEGF）阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・血管内皮増殖因子（VEGF）阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・血管内皮増殖因子（VEGF）阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bayer AG、F. Hoffmann-La Roche Ltd.、Novartis AG、Regeneron Pharmaceuticals Inc.、Sanofi.）
・結論

Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels.
The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of vascular endothelial growth factor can generate cancerous cells.

Market Analysis and Insights: Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
The global Vascular Endothelial Growth Factor (VEGF) Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market.

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Scope and Market Size
Vascular Endothelial Growth Factor (VEGF) Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
VEGF-A Inhibitor
VEGF-B Inhibitor
VEGF-C Inhibitor
VEGF-D Inhibitor

Segment by Application
Oncology
Ophthalmology

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Sanofi.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 VEGF-A Inhibitor
1.2.3 VEGF-B Inhibitor
1.2.4 VEGF-C Inhibitor
1.2.5 VEGF-D Inhibitor
1.3 Market by Application
1.3.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Ophthalmology
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Perspective (2016-2027)
2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Trends by Regions
2.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Dynamic
2.3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Trends
2.3.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Drivers
2.3.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Challenges
2.3.4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Players by Revenue
3.1.1 Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue
3.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Ratio
3.4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue in 2020
3.5 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players Head office and Area Served
3.6 Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Solution and Service
3.7 Date of Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Breakdown Data by Type
4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Type (2022-2027)

5 Vascular Endothelial Growth Factor (VEGF) Inhibitors Breakdown Data by Application
5.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2016-2027)
6.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
6.2.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2027)
6.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
6.3.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2027)
6.4 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
6.4.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2016-2027)
7.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
7.2.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2027)
7.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
7.3.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2027)
7.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
7.4.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
8.2.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
8.3.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region
8.4.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2016-2027)
9.2 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
9.2.1 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
9.3.1 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
9.4.1 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
10.2.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
10.3.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
10.4.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.1.4 Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.3.4 Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Regeneron Pharmaceuticals Inc.
11.4.1 Regeneron Pharmaceuticals Inc. Company Details
11.4.2 Regeneron Pharmaceuticals Inc. Business Overview
11.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.4.4 Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
11.4.5 Regeneron Pharmaceuticals Inc. Recent Development
11.5 Sanofi.
11.5.1 Sanofi. Company Details
11.5.2 Sanofi. Business Overview
11.5.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
11.5.4 Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
11.5.5 Sanofi. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of VEGF-A Inhibitor
Table 3. Key Players of VEGF-B Inhibitor
Table 4. Key Players of VEGF-C Inhibitor
Table 5. Key Players of VEGF-D Inhibitor
Table 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions (2016-2021)
Table 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions (2022-2027)
Table 12. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Trends
Table 13. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Drivers
Table 14. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Challenges
Table 15. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Restraints
Table 16. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Players (2016-2021)
Table 18. Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2020)
Table 19. Ranking of Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Solution and Service
Table 23. Date of Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2016-2021)
Table 27. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2016-2021)
Table 31. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer AG Company Details
Table 64. Bayer AG Business Overview
Table 65. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 66. Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021) & (US$ Million)
Table 67. Bayer AG Recent Development
Table 68. F. Hoffmann-La Roche Ltd. Company Details
Table 69. F. Hoffmann-La Roche Ltd. Business Overview
Table 70. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 71. F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021) & (US$ Million)
Table 72. F. Hoffmann-La Roche Ltd. Recent Development
Table 73. Novartis AG Company Details
Table 74. Novartis AG Business Overview
Table 75. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 76. Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021) & (US$ Million)
Table 77. Novartis AG Recent Development
Table 78. Regeneron Pharmaceuticals Inc. Company Details
Table 79. Regeneron Pharmaceuticals Inc. Business Overview
Table 80. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 81. Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021) & (US$ Million)
Table 82. Regeneron Pharmaceuticals Inc. Recent Development
Table 83. Sanofi. Company Details
Table 84. Sanofi. Business Overview
Table 85. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product
Table 86. Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021) & (US$ Million)
Table 87. Sanofi. Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. VEGF-A Inhibitor Features
Figure 3. VEGF-B Inhibitor Features
Figure 4. VEGF-C Inhibitor Features
Figure 5. VEGF-D Inhibitor Features
Figure 6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application: 2020 VS 2027
Figure 7. Oncology Case Studies
Figure 8. Ophthalmology Case Studies
Figure 9. Vascular Endothelial Growth Factor (VEGF) Inhibitors Report Years Considered
Figure 10. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions: 2020 VS 2027
Figure 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions (2022-2027)
Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Players in 2020
Figure 15. Global Top Vascular Endothelial Growth Factor (VEGF) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue in 2020
Figure 17. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2016-2021)
Figure 18. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Type (2022-2027)
Figure 19. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2016-2027)
Figure 21. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2016-2027)
Figure 22. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2016-2027)
Figure 23. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2016-2027)
Figure 27. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2016-2027)
Figure 28. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2016-2027)
Figure 29. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Region (2016-2027)
Figure 39. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2016-2027)
Figure 47. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2016-2027)
Figure 48. Latin America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2016-2027)
Figure 49. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Country (2016-2027)
Figure 55. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
Figure 59. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
Figure 61. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
Figure 62. Sanofi. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2019-2025
QYR9NV18526 2019年11月18日 91Pages
※当調査レポートでは、血管内皮増殖因子(VEGF)阻害剤の世界市場について調査・分析し、血管内皮増殖因子(VEGF)阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（VEGF-A阻害剤、VEGF...

血管内皮増殖因子(VEGF)阻害剤のグローバル市場：規模・現状・予測2019-2025

世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年）

Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5815 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ヤヌスキナーゼ（JAK）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）、用途別市場規模（自己免疫疾患、腫瘍）、主要...

世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年）

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-5726 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、上皮成長因子受容体（EGFR）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、大腸がん、乳がん、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北...

世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年）

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5949 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その...

世界の副腎皮質ホルモン阻害剤市場規模・現状・予測（2021年-2027年）

Global Adrenal Corticosteroid Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-3766 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、副腎皮質ホルモン阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オシロドロスタット、メチラポン）、用途別市場規模（病院、ホームケア、専門センター、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の酵素ポリADPリボースポリメラーゼ（PARP）阻害剤市場規模・現状・予測（2021年-2027年）

Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-4191 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ニラパリブ（ゼジュラ）、オラパリブ（リンパルザ）、ルカパリブ（ルブラカ）、タラゾパリブ（タルゼンナ）...

世界の凝固第XI因子市場規模・現状・予測（2021年-2027年）

Global Coagulation Factor XI Market Size, Status and Forecast 2021-2027
QFJ1-5665 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、凝固第XI因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MR-1007、IONIS-FXIRx、EP-7041、AB-022、BMS-262084、その他）、用途別市場規模（血栓症、出血＆凝固障...

世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測（2021年-2027年）

Global Transforming Growth Factor Beta 2 Market Size, Status and Forecast 2021-2027
QFJ1-6050 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、トランスフォーミング増殖因子ベータ 2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（XOMA-089、トラベダーセン、ISTH-0047、その他）、用途別市場規模（多形性膠芽腫、開放隅角緑内障、肝線...

世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年）

Global Glial Cell Line Derived Neurotrophic Factor Market Size, Status and Forecast 2021-2027
QFJ1-5755 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、グリア細胞株由来神経栄養因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（GSK-812、LAUR-301、TW-002、AMT-090、その他）、用途別市場規模（筋萎縮性側索硬化症、脳虚血、パーキ...

血管内皮増殖因子(VEGF)阻害剤のグローバル市場：規模・現状・予測2019-2025 Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of …
血管内皮増殖因子(VEGF)阻害剤のグローバル市場：規模・現状・予測2019-2025 Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of …
世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年） The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands. The high efficacy of EGFR inhibitors in the treatment of various types of cancer indicati…
世界の腫瘍壊死因子（TNF）阻害薬市場規模・現状・予測（2021年-2027年） A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, …
世界の酵素ポリADPリボースポリメラーゼ（PARP）阻害剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market The global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standar…